Feasibility of Early Gabapentin as an Intervention for Neurorecovery

Phase 4 Recruiting 42 enrolled MetroHealth Medical Center National Institute on Disability, Independent Living, and Rehabilitation Research · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the proposed study is to conduct the first ever prospective, dose-exploration trial to test the feasibility of early administration of gabapentin as an intervention for neurorecovery. This research project falls under the Intervention Development stage of research as the primary goal is to assess the feasibility of conducting a well-designed intervention efficacy study in the future.

Timeline

Start: 2022-03-14
Primary completion: 2026-08-31
Completion: 2026-08-31

Publications

Wilson JR, Doty S, Petitt JC, El-Abtah M, Francis JJ, Sharpe MG, Kelly ML, Anderson KD. Feasibility of gabapentin as an intervention for neurorecovery after an acute spinal cord injury: Protocol. Front Neurol. 2022 Nov 7;13:1033386. doi: 10.3389/fneur.2022.1033386. eCollection 2022.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gabapentin	Small molecule	600 mg	Oral
Subject	Gabapentin	Small molecule	1800 mg	Oral

Feasibility of Early Gabapentin as an Intervention for Neurorecovery

Summary

Timeline

Publications

Drugs

Indications